Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

313 Items

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Appropriate Surgical Margins and Proper Handling of Soft Tissue Sarcoma of the Extremities

Document Status: Archived
ID: 11-10

Oct 2015

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Document Status: Current

Oct 2019

Best Practice Recommendations for Regimen Development and Maintenance

Document Status: Current
ID: GL-C50-25

Feb 2016

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Document Status: Current

Apr 2020

Bevacizumab for Recurrent Glioblastoma Multiforme (GBM)

Document Status: Archived
ID: CED 19

Jul 2010

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma

Document Status: Archived
ID: 8-3

Sep 2011

Bone Health and Bone-Targeted Therapies for Prostate Cancer

Document Status: Current
ID: 3-14
Version: 2

Sep 2016

Bortezomib in Multiple Myeloma and Lymphoma

Document Status: Archived
ID: 6-18
Version: 2

Jun 2016

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Document Status: Education and Information
ID: 1-2
Version: 2

Sep 2011

Cancer Care Ontario Beyond-Use Date Recommendations Report

Document Status: Current
ID: N/A
Version: 1

Mar 2018